Perioperative high-dose-rate brachytherapy in locally advanced and recurrent gynecological cancer: Final results of a Phase II trial

In the article, Perioperative high-dose-rate brachytherapy in locally advanced and recurrent gynecological cancer: Final results of a phase II trial (Brachytherapy, Volume 17, Issue 5, Pages 734–741, 2018), by Martinez-Monge R et al., the authors did not include their acknowledgment statement: “The authors wish to thank Mr. David Carpenter for editorial assistance. This work was supported by the Fondo de Investigaciones Sanitarias to R.M-M (PI 16/01847)”. Perioperative high-dose-rate brachytherapy in locally advanced and recurrent gynecological cancer: Final results of a Phase II trialBrachytherapyVol. 17Issue 5PreviewTo determine the long-term results of a Phase II trial of perioperative high-dose-rate brachytherapy (PHDRB) in primary advanced or recurrent gynecological cancer. Full-Text PDF